Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Living With Hepatitis C For Dummies PDF full book. Access full book title Living With Hepatitis C For Dummies by Nina L. Paul. Download full books in PDF and EPUB format.
Author: Nina L. Paul Publisher: John Wiley & Sons ISBN: 1118069951 Category : Health & Fitness Languages : en Pages : 314
Book Description
A comprehensive, empathetic guide for anyone suffering from this serious liver disease Approximately 4 million Americans and 170 million people worldwide suffer from hepatitis C, a viral liver disease that is treatable but not curable. It accounts for more than 40 percent of U.S. liver disease deaths-about 8,000 to 10,000 people annually-and is the most common reason for liver transplantation. This compassionate guide explains how hepatitis C affects the liver and the body and provides solid advice on today's treatment options-from drugs (and their side effects) to transplants and alternative therapies-as well as tips on dealing with the emotional and financial burdens the disease brings with it. Nina L Paul, PhD (New York, NY) earned her doctorate in infectious disease epidemiology and immunology from Yale University. She has researched viruses (human immunodeficiency virus and others) and the immune system.
Author: Nina L. Paul Publisher: John Wiley & Sons ISBN: 1118069951 Category : Health & Fitness Languages : en Pages : 314
Book Description
A comprehensive, empathetic guide for anyone suffering from this serious liver disease Approximately 4 million Americans and 170 million people worldwide suffer from hepatitis C, a viral liver disease that is treatable but not curable. It accounts for more than 40 percent of U.S. liver disease deaths-about 8,000 to 10,000 people annually-and is the most common reason for liver transplantation. This compassionate guide explains how hepatitis C affects the liver and the body and provides solid advice on today's treatment options-from drugs (and their side effects) to transplants and alternative therapies-as well as tips on dealing with the emotional and financial burdens the disease brings with it. Nina L Paul, PhD (New York, NY) earned her doctorate in infectious disease epidemiology and immunology from Yale University. She has researched viruses (human immunodeficiency virus and others) and the immune system.
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309438020 Category : Medical Languages : en Pages : 187
Book Description
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309146283 Category : Medical Languages : en Pages : 252
Book Description
The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.
Author: World Health Organization Publisher: World Health Organization ISBN: 9789241549981 Category : Medical Languages : en Pages : 0
Book Description
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviors and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination. These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.
Author: Gregory T. Everson Publisher: ISBN: 9781578264025 Category : Hepatitis C Languages : en Pages : 160
Book Description
Includes a new chapter on long-acting pegylated interferons -- the cuting-edge discovery that is sure to be the next generation of treatment. Since its original publication in 1998, Living with Hepatitis C: A Survivor's Guide has become the resource for hundreds of thousands of American afflicted with the deadly virus -- and for their husbands, wives, families and friends. Unlike other books on the topic, Living with Hepatitis C is written by a nationally recognized hepatitis C expert and his patient. So readers everywhere receive the advice and expertise on one of the country's top hepatologists while gaining invaluable insight and guidance from a patient who has been through it all. This newly revised third edition reviews the results of the latest clinical trials of long-acting, pegylated interferons in a new chapter. It updates all of the organizations, resources, and information that has changed since the last edition. It offers special chapters on research trends, liver transplants (including living-donor transplants), children, co-infection with HIV/AIDS or hepatitis B, as well as chapters devoted to the nutritional, emotional, and financial challenges that accompany infection with hepatitis C.
Author: Lucinda K. Porter Publisher: Square One Publishers, Inc. ISBN: 0757053394 Category : Health & Fitness Languages : en Pages : 227
Book Description
For decades, having hepatitis C virus (HCV) was the equivalent of serving a life sentence—with a dangerous liver disease. All of that changed with the discovery that the virus could be defeated with a new treatment. To shed light on this groundbreaking therapy, Lucinda Porter, a registered nurse, a passionate HCV advocate, and a hep C patient herself, has written a comprehensive guide for people who are undergoing or considering this new hep C treatment. Ms. Porter begins by explaining what hepatitis C is. She then looks at both the mainstream and the alternative management techniques currently used to keep the virus in check. From there, she examines hep C’s new therapy and what you can expect from it. The author demystifies test results, provides important questions you can ask your healthcare provider, and offers advice—all with the compassion of someone who has gone through the process herself. Well over 3 million North Americans live with hepatitis C. Here, at last, is all the information they need to make informed decisions about their future.
Author: Lloyd Wright Publisher: Unistar Books ISBN: Category : Health & Fitness Languages : en Pages : 306
Book Description
Eight Years Ago Lloyd Wright was diagnosed with Chronic Hepatitis C. If experience is the best teacher, then Lloyd Wright is truly an expert. As a Hepatitis C researcher and author. Lloyd has developed more substantial credentials than many doctors or scientists currently treating and researching the virus. Lloyd had Hepatitis C and beat it. Standing up against a legion of medical doctors who insist there is no cure, he researched this disease and he proved them wrong. Now he wants to share this cure with other Hepatitis C sufferers. Book jacket.